Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed.
Beetz NL, Dräger F, Hamm CA, Shnayien S, Rudolph MM, Froböse K, Elezkurtaj S, Haas M, Asbach P, Hamm B, Mahjoub S, Konietschke F, Wechsung M, Balzer F, Cash H, Hofbauer S, Penzkofer T. Beetz NL, et al. Among authors: mahjoub s. Prostate Cancer Prostatic Dis. 2023 Sep;26(3):543-551. doi: 10.1038/s41391-022-00599-2. Epub 2022 Oct 8. Prostate Cancer Prostatic Dis. 2023. PMID: 36209237 Free PMC article.
Active surveillance inclusion criteria under scrutiny in magnetic resonance imaging-guided prostate biopsy: a multicenter cohort study.
Kornienko K, Siegel F, Borkowetz A, Hoffmann MA, Drerup M, Lieb V, Bruendl J, Höfner T, Cash H, von Hardenberg J, Westhoff N; GESRU Academics Prostate Cancer Group. Kornienko K, et al. Prostate Cancer Prostatic Dis. 2022 Mar;25(1):109-116. doi: 10.1038/s41391-021-00478-2. Epub 2021 Dec 17. Prostate Cancer Prostatic Dis. 2022. PMID: 34916584 Free PMC article.
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter Study.
Sigle A, Borkowetz A, von Hardenberg J, Drerup M, Kornienko K, Kwe J, Wenzel M, Mandel P, Westhoff N, Rieger C, Hoffmann MA, Ortner G, Mahjoub S; GeSRU Academics Prostate Cancer Group. Sigle A, et al. Among authors: mahjoub s. Eur Urol Focus. 2023 Jul;9(4):606-613. doi: 10.1016/j.euf.2023.01.020. Epub 2023 Feb 17. Eur Urol Focus. 2023. PMID: 36804191
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment.
Harke NN, Wagner C, Hermann RM, Hadaschik BA, Radtke JP, Altay-Langguth A, Aufderklamm S, Bach C, Becker-Schiebe M, Blana A, Bruns F, Buse S, Combs SE, Engels CL, Ezzibdeh E, Fiedler M, Fischer LA, Farzat M, Frismann A, Heck MM, Henkenberens C, Roesch MC, Käding C, Klautke G, Krausewitz P, Kuczyk MA, Leitsmann C, Lettmaier S, Mahjoub S, Manseck A, Medenwald D, Meyer A, Micke O, Moritz R, Ott M, Peters I, Pokupic S, Porres D, Preisser F, Reichel K, Schneider A, Schwentner C, Scobioala S, Truss M, Wegener D, Wezel F, Willborn K, Witt JH, Wittig A, Wittlinger M, Wolff HA, Zimmermanns V, Christiansen H. Harke NN, et al. Among authors: mahjoub s. PLoS One. 2022 Jun 14;17(6):e0269827. doi: 10.1371/journal.pone.0269827. eCollection 2022. PLoS One. 2022. PMID: 35700180 Free PMC article.
Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancer.
Katzendorn O, von Klot CAJ, Mahjoub S, Faraj Tabrizi P, Harke NN, Tezval H, Hellms S, Hennenlotter J, Baig MS, Stenzl A, Seith F, Lafos M, Kuczyk MA, Rausch S, Peters I. Katzendorn O, et al. Among authors: mahjoub s. PLoS One. 2022 Aug 12;17(8):e0271981. doi: 10.1371/journal.pone.0271981. eCollection 2022. PLoS One. 2022. PMID: 35960727 Free PMC article.
261 results